Micafungin Injection, Powder, For Solution
Product Images NDC 42658-022

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Micafungin (NDC 42658-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hisun Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

11411-draft-inner-carton-100mg-10-pack (11411 Draft Inner Carton 100mg 10 Pack)

11411-draft-inner-carton-100mg-10-pack (11411 Draft Inner Carton 100mg 10 Pack)
This is a description of Micafungin for Injection, USP. Each vial contains 100 mg of micafungin equivalent to 101.73 mg of micafungin sodium. The product is used for intravenous infusion only and requires reconstitution with 0.9% sodium chloride or 5% Dextrose Injection before further dilution. It should be stored at 20 to 25°C, protected from light, and discarded after single use. Manufactured in China and distributed by Hisun Pharmaceuticals USA, Inc.*
FDA Label Image

11411-draft-inner-carton-50mg-10-pack (11411 Draft Inner Carton 50mg 10 Pack)

11411-draft-inner-carton-50mg-10-pack (11411 Draft Inner Carton 50mg 10 Pack)
This is a description of Micafungin for Injection, a sterile and nonpyrogenic medication used for intravenous infusion. Each vial contains 50.86 mg of micafungin sodium along with lactose monohydrate and NF 200 mg with citric acid for pH adjustment. The medication should be stored between 20 to 25°C (68 to 77°F) with excursions permitted between 15 to 30°C (59 to 86°F). It should be protected from light, is preservative-free, and any unused portion should be discarded. The product is distributed by Hisun Pharmaceuticals USA, Inc., and manufactured in China. The medication requires reconstitution with either 0.9% sodium chloride injection or 5% Dextrose Injection before administration, and each mL of the reconstituted solution contains 10 mg of micafungin. Further dilution is necessary before infusion.*
FDA Label Image

11411-draft-vial-label-100mg-10-pack (11411 Draft Vial Label 100mg 10 Pack)

11411-draft-vial-label-100mg-10-pack (11411 Draft Vial Label 100mg 10 Pack)
This text provides information about a vial of micafungin for injection, with each vial containing 100 mg of micafungin equivalent to 101.73 mg micafungin sodium. It includes instructions for dosage, reconstitution, and dilution, as well as storage conditions and the manufacturer's details. The product is sterile, preservative-free, and should be protected from light. The text also states that unused portions should be discarded. The medication is distributed by Hisun Pharmaceuticals USA, Inc. and the product is manufactured in China. The NDC number for the product is 42658-023-01.*
FDA Label Image

11411-draft-vial-label-50mg-10-pack (11411 Draft Vial Label 50mg 10 Pack)

11411-draft-vial-label-50mg-10-pack (11411 Draft Vial Label 50mg 10 Pack)
This text provides information about a Micafungin for Injection product. The vial contains 50 mg of micafungin sodium. Instructions for dosage, reconstitution, and storage are included. It should be stored at 20-25°C and protected from light. The product is distributed by Hisun Pharmaceuticals USA, Inc. and is sterile and preservative-free. Each mL after reconstitution contains 10 mg of micafungin. It is for intravenous infusion use only. The product has an NDC number and is manufactured in China.*
FDA Label Image

Micafungin_sodium_version 03 Us 5kg 20240416 (The Chemical Structure Of Micafungin Sodium Usp)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.